Depression, other comorbidities linked to harsher AS symptoms

Two or more comorbidities affected nearly half of the ankylosing spondylitis (AS) patients in a large study of the disease, with the most common coexisting conditions being uveitis (eye inflammation), depression, and hypertension (high blood pressure). Those with no comorbidities were younger and had shorter disease duration, the researchers reported,…

Gilead Suspends Enrollment in Phase 3 Trials of Filgotinib in AS

Gilead Sciences has suspended enrollment in two Phase 3 trials studying the effects of filgotinib, an anti-inflammatory therapy currently being investigated in several inflammatory conditions, in patients with ankylosing spondylitis (AS). The trials, SEALION2-NAÏVE (NCT04483700) and SEALION1-IR (NCT04483687), set out to determine if filgotinib is potentially…

Genetic Marker HLA-B27 Correlates With Ankylosing Spondylitis Onset but Not Disease Burden, Study Shows

The presence of a specific genetic marker called HLA-B27 in Caucasian ankylosing spondylitis patients is related to earlier disease onset and higher disease prevalence among family members, a study has found. However, according to the research, being HLAB27-positive is not related to a higher burden of disease or uveitis (inflammation of the eye).

Anterior Uveitis Increases Risk of Developing Ankylosing Spondylitis, Study Finds

The risk of developing ankylosing spondylitis is significantly higher following past episodes of anterior uveitis, a type of eye inflammation, according to researchers. This finding emphasizes the importance of a multidisciplinary approach in the diagnosis and management of ankylosing spondylitis (AS). The study, “Recurrent anterior uveitis and subsequent incidence of ankylosing…